# Taysha Gene Therapies, Inc.: Form 8-K, filed May 30, 2024

- Company: [Taysha Gene Therapies, Inc.](/companies/tsha.md) (CIK 1806310)
- Form: 8-K
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 16:02 ET
- Period: 2024-05-29
- Accession: 0001193125-24-150323
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806310/000119312524150323/d805768d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806310/000119312524150323/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806310/000119312524150323/d805768d8k.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-150323. Last ingested by Listed: Nov 12, 2026, 18:00 ET. No prices; not investment advice.